Document is current
Any future updates will be listed below
-
Authors
Hidaka, Hidenori
Higashimoto, Ken
Aoki, Saori
Mishima, Hiroyuki
Hayashida, Chisa
Maeda, Toshiyuki
Koga, Yasuo
Yatsuki, Hitomi
Joh, Keiichiro
Noshiro, Hirokazu
Iwakiri, Ryuichi
Kawaguchi, Atsushi
Yoshiura, Koh-ichiro
Fujimoto, Kazuma
Soejima, Hidenobu https://orcid.org/0000-0001-5076-6563
-
Funding
Funding for this research was provided by:
AstraZeneca (201500315)
Japan Society for the Promotion of Science (16K09970, 17K08687, 17K09307)
Japan Agency for Medical Research and Development (17ek0109280h0001, 17ek0109234h0001, 17ek0109205h0001)
Ministry of Health, Labour and Welfare (26-13, H29-nanchitou(nan)-ippan-025)
Gunma University (16029)
- License Information
-
More Information
Article History
Received: 12 September 2018
Accepted: 5 November 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: This study was approved by the Ethics Committee for Human Genome and Gene Analyses of the Faculty of Medicine at Saga University. Written informed consent was obtained from the patients.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
